CD4 and parasitic infectious disease: Therefore, the partial protection seen in this clinical trial could be interpreted as consistent with the murine study, since the delay to parasitemia in two volunteers may also have resulted from a reduction in the numbers of liver stages by vaccine-induced CD4+ and/or CD8+ T cells.